In a new job – December 11, 2025
NMD Pharma has announced the appointment of Ana de Vera as Chief Medical Officer (CMO), effective immediately.
Clinical Trials – December 11, 2025
It is a phase 1 single-ascending dose/multiple-ascending dose study of lead asset MNA-001 in healthy adult participants.
Event Highlights – December 10, 2025
InLifeScience 2025 showed how vulnerable supply-chains have become and why geoeconomics force us to be more resilient, reports The Life Science Cluster.
Acquisition – December 10, 2025
LINK Medical has announced the transfer of specific business areas from SDS Life Science (an affiliate of Cytel), namely the Drug Development Consulting and Clinical Project Management/Medical Writing units.
Clinical Trials – December 10, 2025
AnaCardio has announced topline results from the Phase 2a portion of its GOAL-HF1 clinical study program evaluating AC01 in patients with heart failure and reduced ejection fraction (HFrEF).
SwedenBIO – December 10, 2025
SwedenBIO recently released our new Swedish Drug Discovery and Development Pipeline Report 2026 at NLSDays in Gothenburg. This fourteenth edition once again shows that Swedish drug development remains on a stable trajectory. Fluctuations in the number of drug-developing companies and in the number or type of projects are minimal compared to our report from three years ago.
Clinical Trials – December 11, 2025
It is a phase 1 single-ascending dose/multiple-ascending dose study of lead asset MNA-001 in healthy adult participants.
Clinical Trials – December 10, 2025
AnaCardio has announced topline results from the Phase 2a portion of its GOAL-HF1 clinical study program evaluating AC01 in patients with heart failure and reduced ejection fraction (HFrEF).
Clinical Trials – December 8, 2025
The company has announced positive blinded evaluator efficacy results and completion of the Database Lock (DBL) in its DIAMEND Phase 2 clinical trial of AUP-16, the company’s lead asset for the treatment of non-healing neuro-ischemic Diabetic Foot Ulcers (DFUs).
Clinical Trials – November 26, 2025
The first subject has been dosed in the company’s ODIN Phase 1/2 clinical trial evaluating TH9619, a first-in-class MTHFD1/2 inhibitor.
Clinical Trials – November 21, 2025
Evaxion is advancing its novel multi-component cytomegalovirus (CMV) vaccine program, EVX-V1, with new data demonstrating protective effects of lead antigens in the program.
Clinical Trials – November 13, 2025
Lytix Biopharma has announced promising interim results from an ongoing investigator-initiated Phase 2 NeoLIPA study evaluating ruxotemitide (formerly LTX-315) in combination with pembrolizumab as neoadjuvant therapy in resectable melanoma.
Pharma Business – December 9, 2025
The US Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for TCP-25, a novel topical immunomodulatory peptide being developed for the treatment of Epidermolysis Bullosa (EB).
New Market – December 9, 2025
Cinclus Pharma Holding’s drug linaprazan glurate has been included in China’s 2025 National Reimbursement Drug List (NRDL) for the treatment of gastroesophageal reflux disease (GERD).
Pharma Business – December 3, 2025
After a comprehensive assessment of the latest process dynamics, Lundbeck has concluded that increasing the purchase price set out in its non-binding proposal announced on November 14 would not meet its strategic or financial criteria for value creation.
MedTech Business – December 9, 2025
CellaVision has announced that its new CellaVision Bone Marrow Aspirate (BMA) Application has received CE marking approval as a Class C product under the European Union In Vitro Diagnostic Regulation (EU IVDR).
Agreement – December 8, 2025
The company has signed an agreement with an IDN (Integrated Delivery Network) in the Western US, marking the company’s most significant opportunity for sales growth in the region to date it states.
MedTech Business – December 3, 2025
Ingrid Stenstadvold Ross, Secretary-General of the Norwegian Cancer Society, presented the innovation award, accompanied by a prize of NOK 300,000, to the bladder cancer company Photocure. “Building on our success and expertise, we aim to create a suite of complementary precision diagnostic solutions to address the evolving needs of patients, physicians, and the broader healthcare […]
Biotech Business – December 9, 2025
BioArctic’s partner Eisai has announced that Leqembi (lecanemab), has been included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China.
Biotech Business – December 2, 2025
The collaboration concerns the handling, freezing, storage, and transport of cell products used for research and development.
Biotech Business – November 28, 2025
Medivir’s selective cathepsin K inhibitor, MIV-711, has been granted Orphan Drug Designation (ODD) by the FDA for the treatment of Osteogenesis Imperfecta (OI).
Science News – December 1, 2025
Researchers at Chalmers University of Technology have found a new weapon to fight bacterial growth on surfaces like implants or in catheters.
Funding – November 28, 2025
The Promobilia Foundation has donated SEK 30 million to Linköping University for an interdisciplinary research project where organic electronics will be used to treat Parkinson’s disease symptoms. Stiftelsen för Parkinsonsforskning at LiU has also donated SEK 5 million to the purpose, and LiU is adding SEK 10 million.
Science Award – October 24, 2025
Julia Ravanis is awarded Forskningsfyren 2025 “for her innovative way of spreading knowledge across generational boundaries through a unique union of poetry, humanities and natural sciences.”
Stryker
In this role, you will help us deliver on our mission of making healthcare better by promoting and selling Stryker’s ST product portfolio across Southern Finland.
Stryker
In this role, you will help us deliver on our mission of making healthcare better by promoting and selling Stryker’s ST product portfolio across Northern Finland.
Stryker
This is a high-impact role where you’ll combine strategic leadership with hands-on field presence, driving double-digit growth and building a strong, motivated team identity.
Stryker
In this position, you will be responsible for the strategy and management of your sales area (Nordics), the leadership of your team as well as sales/turnover and cost so that optimized customer service and acquisition of new customers is guaranteed.
Stryker
Are you a driven, ambitious sales professional looking to take your career to the next level? If so, this is your opportunity to thrive.
Stryker
Due to expansion in Lund, Stryker is recruiting for a new Design Quality Assurance Engineer to add the team. This person will partner with cross-functional project teams in New Product Development (NPD) and Engineering Projects during the product development and change control processes to drive quality assurance.
In a new job – December 9, 2025
Niels Buch Leander has been appointed new Chief Digital Officer (CDO) and Executive Vice President (EVP) Denmark.
In a new job – December 9, 2025
Mathias Meijer joins Medicon Valley Alliance (MVA) with 14 years of experience developing major research, innovation and implementation projects across sectors.
In a new job – December 8, 2025
Sigurdur Agust Einarsson has been appointed to the new position of Director of Engineering Operations at Coripharma.
Careers article – November 26, 2025
As a consequence of a zero-based review of the organization, Elekta will reduce its global workforce by approximately 450 employees with a major effect on managerial positions.
Careers article – November 14, 2025
On November 13, the day before the company’s Extraordinary General Meeting, it was announced that Mikael Dolsten will not seek election to the Board of Directors as otherwise announced in the notice convening the meeting.
Careers article – November 2, 2025
Imagine your job involves meeting with entrepreneurs and researchers who are passionate about developing drugs that could transform or save lives, and realizing you could be part of that future. That is just another “day at the office” for Ester Sklarsky, who has been a principal for the Swedish venture capital firm Sound Bioventures for the past three and a half years.
Profiles in Business – December 8, 2025
Successful businessman and former chairman of AstraZeneca, Leif Johansson, has accumulated vast experience and knowledge about international competition, leadership, business development, and entrepreneurship, not least when it comes to science-driven industries like the life science industry.
Nobel Prize 2025 – November 25, 2025
With a family legacy in medicine dating back to the Shogun era, the Japanese immunologist Dr. Shimon Sakaguchi has dedicated his career to the science. A 30-year-old pivotal discovery led him to this year’s Nobel Prize in Physiology or Medicine for research in peripheral immune tolerance.
Nobel Prize 2025 – November 25, 2025
Nobel Prize laureate Mary E. Brunkow’s career path has shifted between industry and academia but her end goal to generate clinical benefit and her passion for exploring new areas have never wavered.
This site uses cookies
